Ischemic stroke in a 7-Month-old infant with antiphospholipid antibody and homozygous C677T methylenetetrahydrofolate reductase (MTHFR) polymorphism

Journal of Child Neurology

Volumn 25, Issue 8, 2010, Pages 1047-1050

  Kim, Se Hee ^a   Hwang, Hee ^a   Chae, Jong Hee ^a   Kim, Ki Joong ^a   Hwang, Yong Seung ^a   Lim, Byung Chan ^a  

^a Seoul National University   (South Korea)

Author keywords

antiphospholipid antibody; infant; methylenetetrahydrofolate reductase; risk factor; stroke

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; HOMOCYSTEINE; IMMUNOGLOBULIN M ANTIBODY; LIPOPROTEIN A; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S;

ANTIBODY PRODUCTION; ARTICLE; BABINSKI REFLEX; BRAIN INFARCTION; BRAIN ISCHEMIA; CASE REPORT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DNA POLYMORPHISM; FACE MUSCLE; FOLLOW UP; GENETIC CORRELATION; GENOTYPE; HEMIPARESIS; HOMOZYGOSITY; HOSPITAL ADMISSION; HUMAN; INFANCY; INFANT; MALE; MUSCLE STRENGTH; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOTHERAPY; PRIORITY JOURNAL; PROTHROMBIN DEFICIENCY; RISK ASSESSMENT; RISK FACTOR; TWINS;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BRAIN ISCHEMIA; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PARESIS; POLYMORPHISM, GENETIC; RISK FACTORS; STROKE;

EID: 77954694567     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073809356710     Document Type: Article

References (11)

1. Bernard TJ, Goldenberg NA Pediatric arterial ischemic stroke. Pediatr Clin North Am. 2008 ; 55: 323-338, viii.
2. Kenet G., Sadetzki S., Murad H., et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000 ; 31: 1283-1288.
3. Haywood S., Liesner R., Pindora S., Ganesan V. Thrombophilia and first arterial ischaemic stroke: a systematic review. Arch Dis Child. 2005 ; 90: 402-405.
4. Herak DC, Antolic MR, Krleza JL, et al. Inherited prothrombotic risk factors in children with stroke, transient ischemic attack, or migraine. Pediatrics. 2009 ; 123: e653-660.
5. Avcin T., Cimaz R., Silverman ED, et al. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics. 2008 ; 122: e1100-1107.
6. Simchen MJ, Goldstein G., Lubetsky A., et al. Factor V Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke. Stroke. 2009 ; 40: 65-70.
7. Boffa MC, Lachassinne E. Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus. 2007 ; 16: 634-641.
8. Paro-Panjan D., Kitanovski L., Avcin T. Neonatal antiphospholipid syndrome associated with heterozygous methylenetetrahydrofolate reductase C677T and prothrombin G20210A gene mutations. Rheumatology (Oxford). 2007 ; 46: 720-721.
9. Goldberg SN, Conti-Kelly AM, Greco TP A family study of anticardiolipin antibodies and associated clinical conditions. Am J Med. 1995 ; 99: 473-479.
10. Soares Rolim AM, Castro M., Santiago MB Neonatal antiphospholipid syndrome. Lupus. 2006 ; 15: 301-303.
11. Berkun Y., Padeh S., Barash J., et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum. 2006 ; 55: 850-855.